AFFiRiS is a company that delivers therapies to patients with neurodegenerative diseases. Its specific active immunotherapy (SAIT) stimulates the body’s own immune system to find and fight proteins central to the development and progression of neurodegenerative diseases. SAIT is developed using AFFITOME technology, which allows for the optimization of immune responses against pathogenic forms of proteins.